Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05388981 · ClinicalTrials.gov registry record · Phase 1
Study of Single Doses of SBT115301 in Healthy Participants
A Phase 1 study, sponsored by Sonoma Biotherapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT05388981 is a Phase 1 study that has completed, run by Sonoma Biotherapeutics. The registered enrollment target is 40 participants.
The verdict
NCT05388981, a Phase 1 study, has completed, sponsored by Sonoma Biotherapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This study will test the safety and effects of SBT115301 when given as a single dose to healthy adult volunteers. It is the first study being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown. Some participants will receive placebo, and neither the participants or the study staff will know what drug (SBT115301 or placebo) is being given.
Interventions
- BIOLOGICAL Placebo
- BIOLOGICAL SBT115301
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-07-25 |
| Est. Completion | 2024-01-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05388981
The ClinicalTrials.gov registry entry for NCT05388981 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sonoma Biotherapeutics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05388981 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05388981 about?
NCT05388981 is a clinical study titled "Study of Single Doses of SBT115301 in Healthy Participants". This study will test the safety and effects of SBT115301 when given as a single dose to healthy adult volunteers. It is the first study being done in humans. Increasing dose levels will be given after the safety at lower dose levels is shown. Some participants will receive placebo, and neither the p...
What is the current status of trial NCT05388981?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2022-07-25. Estimated completion is 2024-01-03.
What interventions are being tested in trial NCT05388981?
The interventions under investigation include: Placebo (BIOLOGICAL), SBT115301 (BIOLOGICAL).
Who is sponsoring clinical trial NCT05388981?
This trial is sponsored by Sonoma Biotherapeutics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.